---
title: "Barclays maintains Trex Co at Underweight, raises price target to $46 from $42"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304515359.md"
description: "Barclays maintained its Underweight rating on Trex Co but raised its price target to $46 from $42. This new target implies a 19.5% downside from the November 4 close of $57.15. The update is part of recent analyst activity, with other firms like Truist, B of A Securities, Stifel, and Deutsche Bank recently maintaining or upgrading their ratings on the stock."
datetime: "2026-11-05T19:11:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304515359.md)
  - [en](https://longbridge.com/en/news/304515359.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304515359.md)
generator: "portal-rs"
---

# Barclays maintains Trex Co at Underweight, raises price target to $46 from $42

Barclays maintained Trex Co at Underweight and raised its price target to $46 from $42, a 9.5% increase.

The price target implies a downside of 19.5% from the Nov 4 close of $57.15.

**Recent analyst actions on Trex Co**

| Date   | Firm              | Action    | Rating | Price target |
| ------ | ----------------- | --------- | ------ | ------------ |
| Nov 5  | Truist Securities | Maintains | Buy    | $75          |
| Nov 5  | B of A Securities | Upgrades  | Buy    | $65          |
| Oct 20 | Stifel            | Upgrades  | Buy    | $55          |
| Oct 8  | Deutsche Bank     | Upgrades  | Buy    | $57          |

Across the four most recent analyst notes published on Trex Co over the past 30 days, price targets range from $55 to $75.

Explore more price target data and ratings for Trex Co on the , and track all previous and future analyst recommendations in the dedicated News Flow.

**Disclaimer**

Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [TREX.US](https://longbridge.com/en/quote/TREX.US.md)

## Related News & Research

- [Trex lifts full-year sales and EBITDA outlook after record Q3 sales](https://longbridge.com/en/news/304267972.md)
- [TREX: Record Q3 sales and raised guidance offset by margin pressure from costs and Arkansas ramp-up](https://longbridge.com/en/news/304266232.md)
- [Trex Q3 net sales rise 26% on volumes, adjusted EPS beats estimates](https://longbridge.com/en/news/304268130.md)
- [What to expect from Trex’s (TREX) Q3 earnings](https://longbridge.com/en/news/304045416.md)
- [Cantor Fitzgerald maintains Zevra Therapeutics at Overweight, lowers price target to $19 from $25](https://longbridge.com/en/news/305495771.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**